Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith A Newton

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of Medicine|February 11, 2023
Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinomaWesley C Burkett, Ziyi Zhao, Meredith A Newton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2026
Management of medically inoperable low-grade endometrial cancer: patterns of care and outcomes with radiation, brachytherapy, and hormonal therapyKevin Tam, Leslie D Peralta, Glenn P Boyles, et al.
Cancers|November 25, 2023
Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial CancerBoer Deng, Weimin Kong, Hongyan Suo, et al.
Biomolecules|May 24, 2024
Palmitic Acid Exerts Anti-Tumorigenic Activities by Modulating Cellular Stress and Lipid Droplet Formation in Endometrial CancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Gynecologic Oncology Reports|July 21, 2025
Racial differences in endometrial cancer genomics and outcomes using UNCseq<sup>TM</sup> targeted DNA sequencingMeredith A Newton, Jason D Merker, Weida Gong, et al.
Gynecologic Oncology|April 26, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of Medicine|February 11, 2023
Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinomaWesley C Burkett, Ziyi Zhao, Meredith A Newton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2026
Management of medically inoperable low-grade endometrial cancer: patterns of care and outcomes with radiation, brachytherapy, and hormonal therapyKevin Tam, Leslie D Peralta, Glenn P Boyles, et al.
Cancers|November 25, 2023
Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial CancerBoer Deng, Weimin Kong, Hongyan Suo, et al.
Biomolecules|May 24, 2024
Palmitic Acid Exerts Anti-Tumorigenic Activities by Modulating Cellular Stress and Lipid Droplet Formation in Endometrial CancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Gynecologic Oncology Reports|July 21, 2025
Racial differences in endometrial cancer genomics and outcomes using UNCseq<sup>TM</sup> targeted DNA sequencingMeredith A Newton, Jason D Merker, Weida Gong, et al.
Gynecologic Oncology|April 26, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Pageof 1